Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 2 - Number 2

Recombinant Adenovirus-mediated Cytotoxic Gene Therapy and Lymphoproliferative Disorders: Analysis Based on Pharmacodynamics

, 2(2): 109 - 118

Francesco Turturro


DOI: 10.2174/1568008023340703




Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes

, 2(2): 119 - 127

Nicolas Musi and Laurie J. Goodyear


DOI: 10.2174/1568005310202020119




Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic β Cell Function: Potential Therapeutic Implications

, 2(2): 129 - 139

A. Kowluru and R. Amin


DOI: 10.2174/1568005310202020129




Novel Targets for Therapy in Paediatric Oncology

, 2(2): 141 - 150

E. J. Estlin


DOI: 10.2174/1568005310202020141




Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia

, 2(2): 151 - 165

M. C. Sugden and M. J. Holness


DOI: 10.2174/1568005310202020151




Molecular Basis of Hyperparathyroidism and Potential Targets for Drug Development

, 2(2): 167 - 179

L. J. Krebs and A. Arnold


DOI: 10.2174/1568005310202020167




Apoptotic Cell Death in Renal Injury: The Rationale for Intervention

, 2(2): 181 - 192

A. Ortiz, P. Justo, M. P. catalan, A. B. Sanz, C. Lorz and J. Egido


DOI: 10.2174/1568005310202020181




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science